Tag results:
T cells
Extracellular Matrix News
An Immunologically Active, Adipose-Derived Extracellular Matrix Biomaterial for Soft Tissue Reconstruction: Concept to Clinical Trial
[NPJ Regenerative Medicine] Researchers developed an “off-the-shelf” adipose ECM biomaterial from allograft human tissue, applying physical and chemical processing methods to remove lipids and create an injectable matrix that mimicked the properties of lipoaspirate.
Cell Therapy News
Overview of the Pre-Clinical and Clinical Studies about the Use of CAR-T Cell Therapy of Cancer Combined with Oncolytic Viruses
[World Journal of Surgical Oncology] CAR-T cell therapy and oncolytic viruses are innovative cancer therapeutic approaches with fewer complications than common treatments such as chemotherapy and radiotherapy and significantly improve the quality of life.
Human Immunology News
Reinvestigation of Classic T Cell Subsets and Identification of Novel Cell Subpopulations by Single-Cell RNA Sequencing
[Journal of Immunology] The authors integrated six bead-enriched T cell subsets with 62,235 single-cell transcriptomes from human PBMCs and clustered them into nine scRNA-seq clustered populations.
Human Immunology News
Circulating CD8+ Mucosal-Associated Invariant T Cells Correlate with Improved Treatment Responses and Overall Survival in Anti-PD-1-Treated Melanoma Patients
[Clinical & Translational Immunology] Investigators analyzed the frequency and functional profile of circulating and tumor-infiltrating mucosal-associated invariant T cells in human melanoma patients. Using flow cytometry, they compared these across metastatic sites and between ICI responders vs. non-responders as well as healthy donors.
Human Immunology News
Demethylase JMJD2D Induces PD-L1 Expression to Promote Colorectal Cancer Immune Escape by Enhancing IFNGR1-STAT3-IRF1 Signaling
[Oncogene] Scientists reported that both PD-L1 and JMJD2D were frequently overexpressed in human colorectal cancer specimens with a significant positive correlation.
Human Immunology News
Key Interactions in the Trimolecular Complex Consisting of the Rheumatoid Arthritis-Associated DRB1*04:01 Molecule, the Major Glycosylated Collagen II Peptide and the T Cell Receptor
[Annals of the Rheumatic Diseases] The crystal structures identified peptide binding to DRB1*04:01 and potential side chain exposure to T cells.